Siemens Healthineers AG

SHL1

Company Profile

  • Business description

    Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2024) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (17% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (20%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. Americas represents 42% of total sales, Europe, Middle East, and Africa 33%, and Asia-Pacific including China the remainder.

  • Contact

    Siemensstrasse 3
    ForchheimBY91301
    DEU

    T: +49 9131843385

    https://www.siemens-healthineers.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    30 September 2026

    Employees

    73,840

Stocks News & Analysis

stocks

Here’s 3 Top Rated ASX shares for 2026

As we start the new year, let’s take a closer look at three compelling opportunities on the ASX
stocks

Undervalued Aussie e-commerce winner

Shares attractive due to near term profit margin increase and structural growth.
stocks

Our view on oil prices after Maduro is deposed

We’ve revisited our oil price assumptions after the news from Venezuela.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,022.701.50-0.02%
CAC 408,233.923.51-0.04%
DAX 4025,122.26230.060.92%
Dow JONES (US)48,996.08466.00-0.94%
FTSE 10010,048.2174.52-0.74%
HKSE26,458.95251.50-0.94%
NASDAQ23,584.2837.100.16%
Nikkei 22551,961.98556.10-1.06%
NZX 50 Index13,688.5526.47-0.19%
S&P 5006,920.9323.89-0.34%
S&P/ASX 2008,697.605.00-0.06%
SSE Composite Index4,085.772.100.05%

Market Movers